Form 4: Dexcom Director Sells Shares
Insider Transaction (Form 4)
Mark G Foletta, a Director of Dexcom Inc, sold 4,000 shares of common stock on July 31, 2026.
Summary
- Open-market sale: disposed of 2,000 Common Stock at $80.00 ($160,000) on July 31, 2026; holds 50,852 after (Indirect).
- Open-market sale: disposed of 2,000 Common Stock at $85.32 ($170,640) on August 3, 2026; holds 48,852 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $330,640 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Mark G Foletta — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Open-market sale | Common Stock | 2,000 | $80 | $160.0K | 50,852 |
| 2026-08-03 | Open-market sale | Common Stock | 2,000 | $85 | $170.6K | 48,852 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Open-market sale (2,000 shares) |
| 2026-08-03 | Open-market sale (2,000 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, bearish, Mark G Foletta
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.